Skip to Content

FDA Approves CaloMist Nasal Spray for Vitamin B12 Deficiency

The United States Food and Drug Administration (FDA) has approved CaloMist Nasal Spray (cyanocobalamin, USP) for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with vitamin B12 deficiency who have no nervous system involvement.

CaloMist (cyanocobalamin) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.